DiNuzzo Private Wealth’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59K Hold
7
﹤0.01% 762
2026
Q1
$1.21K Hold
7
﹤0.01% 818
2025
Q4
$1.4K Buy
7
+2
+40% +$363 ﹤0.01% 764
2025
Q3
$817 Buy
5
+4
+400% +$635 ﹤0.01% 938
2025
Q2
$152 Sell
1
-3
-75% -$400 ﹤0.01% 1275
2025
Q1
$603 Sell
4
-2
-33% -$335 ﹤0.01% 986
2024
Q4
$1.11K Hold
6
﹤0.01% 812
2024
Q3
$1.18K Sell
6
-1
-14% -$208 ﹤0.01% 799
2024
Q2
$1.45K Buy
7
+2
+40% +$453 ﹤0.01% 635
2024
Q1
$1.35K Hold
5
﹤0.01% 621
2023
Q4
$1.18K Buy
+5
New +$983 ﹤0.01% 643

Other funds holding CRL

DiNuzzo Private Wealth's CRL Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Charles River Laboratories (CRL) position steady in Q2 2026 at 7 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

DiNuzzo Private Wealth first reported a position in CRL in Q4 2023 and has held it in 11 quarters since. 153 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • DiNuzzo Private Wealth held 7 shares of Charles River Laboratories worth $1.59K as of Q2 2026.
  • DiNuzzo Private Wealth left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #762 holding.
  • DiNuzzo Private Wealth first reported a position in Charles River Laboratories in Q4 2023 and has held it in 11 quarters since.
  • 153 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.